Toggle News Sections
Press Release: Leading Health Experts Urge Revisions to FDA Reform Bill
FOR IMMEDIATE RELEASE Doctors for America PO Box 53313 1921 Florida Ave NW Washington, DC 20009-9997 Candy Tai Communications Manager Doctors for America [email protected] Claire Onyechi Continuum Health Group [email protected]…
Read PostPress Release: Doctors for America’s FDA Task Force Meets with Policymakers
FOR IMMEDIATE RELEASE May 16, 2022 Doctors for America’s FDA Task Force Meets with Policymakers Washington, D.C.: This week Doctors for America’s Food and Drug Administration (FDA) Task Force is…
Read PostPress release: Push For Lower Rx Prices: Over 70 Organizations Call For Meaningful Progress On Comprehensive Drug Pricing Reforms By Memorial Day
Click for PDF version FOR IMMEDIATE RELEASE Doctors for America PO Box 53313 1921 Florida Ave NW Washington, DC 20009-9997 Candy Tai Communications Manager Doctors for America [email protected] Push…
Read PostDFA Applauds National Orders Cracking Down on Ghost Guns & Prioritizing ATF Leadership
This announcement from the Biden Administration is an important step toward a safer country for us all. Doctors for America is proud to have worked on advocating for this new…
Read PostPress Release: Doctors for America Hosts Day of Action Advothon to Put Constituents First and Support Access to Affordable Health Care
Click here to download a PDF of this press release FOR IMMEDIATE RELEASE Doctors for America PO Box 53313 1921 Florida Ave NW Washington, DC 20009-9997 Candy Tai Digital Communications…
Read PostPublic Comment from Doctors for America to the Centers for Medicare and Medicaid Services on “Proposed National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease” (CAG-00460N)
Doctors for America commends the Centers for Medicare and Medicaid Services (CMS) for their proposed national coverage decision regarding “Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease”…
Read PostWritten Testimony of Reshma Ramachandran, M.D., M.P.P. at Hearing on “FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics” Subcommittee on Health
Written Testimony of Reshma Ramachandran, M.D., M.P.P. of Yale School of Medicine Hearing on “FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics” Subcommittee on Health U.S. House…
Read PostDFA urges members to contact lawmakers and write op-eds on gun violence
Click on the link to send a pre-written message to the legislators in your district. You can add to the message and share a personal or patient story or send…
Read PostPHYSICIAN MEMBER SPOTLIGHT: Meenakshi Bewtra, MD, MPH, PHD
Meena is an Assistant Professor of Medicine and Epidemiology at the University of Pennsylvania Perelman School of Medicine; and a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics…
Read Post